Novartis Pharmaceutical Corporation v. Plexxikon Inc. > Summary
Court Case Number PGR2018-00069
Filing Date Jun 18, 2018
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesSheridan K. Snedden, Jo-Anne M. Kokoski, Kristi L. R. Sawert
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1, 2, 4, 5, 6, 7, 8, 9, 11, 12, 14, 15, 16, 17, 18, 19
Plaintiff
Plaintiff Attorneys
Novartis
Attorney Name: Phillippe Baran
McDermott Will & Emery
Defendant Attorneys
11Novartis
Attorney Name: Robert H. Underwood
McDermott Will & Emery
wu
Attorney Name: Elizabeth S. Weiswasser
Weil, Gotshal & Manges
wu
Attorney Name: Derek C. Walter
Weil, Gotshal & Manges
wu
Attorney Name: Brian C. Chang
Weil, Gotshal & Manges
Novartis
Attorney Name: Andrew R. Basile Jr.
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Andrew R. Basile
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Jeffrey D. Wilson
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Ryan T. McCleary
Young Basile Hanlon & MacFarlane P.C.
Novartis
Attorney Name: Thomas P. Steindler
McDermott Will & Emery
wu
Attorney Name: Timothy J. Andersen
Weil, Gotshal & Manges
wu
Attorney Name: Anna E. Dwyer
Weil, Gotshal & Manges
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09844539 | Compounds and methods for kinase modulation, and indications therefor | Dec 19, 2017 |
